Edition:
United States

Quintiles IMS Holdings Inc (Q.N)

Q.N on New York Stock Exchange

103.03USD
20 Oct 2017
Change (% chg)

$1.21 (+1.19%)
Prev Close
$101.82
Open
$102.24
Day's High
$103.38
Day's Low
$101.94
Volume
420,890
Avg. Vol
508,764
52-wk High
$103.38
52-wk Low
$70.10

Chart for

About

Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $22,162.33
Shares Outstanding(Mil.): 215.11
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.38 16.52
EPS (TTM): -- -- --
ROI: -- 2.39 11.32
ROE: -- 3.35 15.18

BRIEF-Quintilesims announces pricing of secondary public offering at $95.25 per share

* Quintiles IMS announces pricing of secondary public offering

Sep 15 2017

BRIEF-QUINTILESIMS SAYS LAUNCH OF SECONDARY PUBLIC OFFERING

* QUINTILESIMS ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK

Sep 14 2017

BRIEF-Quintiles IMS Holdings announces pricing on offering of senior notes

* Quintiles IMS Holdings Inc announces pricing on offering of senior notes

Sep 11 2017

BRIEF-Quintiles IMS announces offering of senior notes

* Quintiles IMS announces offering of senior notes, redemption of existing euro senior notes and proposed amendment to senior secured credit facility

Sep 11 2017

EQT to acquire pharmaceutical services firm Certara

Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

Jul 11 2017

UPDATE 1-EQT to acquire pharmaceutical services firm Certara

July 11 Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

Jul 11 2017

Quintiles IMS explores sale of contract sales business: sources

Clinical researcher and pharmaceutical market data specialist Quintiles IMS Holdings Inc is exploring a sale of its contract sales business that could value it at as much as $1 billion, according to people familiar with the matter.

Jun 21 2017

Quintiles IMS explores sale of contract sales business -sources

June 21 Clinical researcher and pharmaceutical market data specialist Quintiles IMS Holdings Inc is exploring a sale of its contract sales business that could value it at as much as $1 billion, according to people familiar with the matter.

Jun 21 2017

BRIEF-Quintiles IMS Holdings files for potential stock shelf

* Quintiles ims holdings inc files for potential stock shelf, size undisclosed - sec filing Source text for Eikon: Further company coverage:

May 24 2017

BRIEF-QuintilesIMS announces launch of secondary public offering

* Quintilesims announces launch of secondary public offering, repurchase of common stock and increase in share buyback authorization

May 24 2017

Earnings vs. Estimates